ESMO Congress 2025 and EONS18
Paxman-Supported Symposium: ‘Strategies for Chemotherapy-Induced Side-Effect Management: Preventing CIPN with Cryotherapy’ .
Monday 20 October 13:15 CET
Potsdam Auditorium Hall 5.1
Symposium chair:
Mary Tanay, RN, PhDa
Consultant Nurse in Genomics at Berkshire Cancer Centre – Royal Berkshire NHS Trust
Visiting Lecturer at the Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King’s College London
Guest speakers:
Elahe Salehi, DNP, ANP-BC
Nurse Practitioner at the Dana-Farber Cancer Institute
Maryam Lustberg, MD, MPH
Director Breast Center/Chief Breast Oncology at Yale University School of Medicine
Hope Rugo, MD
Division Chief of Breast Medical Oncology and a Professor of Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Explore the topics discussed in the Paxman supported satellite symposium at EONS18.
CIPN can affect patients undergoing neurotoxic chemotherapy, with far-reaching consequences for physical functioning, psychological wellbeing, and treatment adherence. This focused symposium brought together nursing, oncology, and research leaders to explore the latest in CIPN assessment, management, and innovation.
Topics include: the clinical burden of CIPN, current strategies in clinical practice, patient advocacy, and emerging medical devices such as cryocompression therapy.
View each of our esteemed speakers’ presentations here.
The prevalence and impact of CIPN on the outcome of cancer patients.
Presented by: Elahe Salehi
Current strategies in clinical practice to support and advocate for patients experiencing CIPN
Presented by: Maryam Lustberg
Review the development of new medical devices for the management of CIPN in chemotherapy settings
Presented by: Rachel wong su jen
